Valuation: Avantor, Inc.

Market Cap 10.34B 9.12B 8.62B 7.82B 14.67B 992B 14.8B 103B 39.79B 507B 38.83B 37.98B 1,626B P/E 2026 *
45.8x
P/E 2027 * 32.8x
Enterprise Value 13.4B 11.82B 11.17B 10.13B 19.02B 1,286B 19.19B 134B 51.57B 657B 50.33B 49.23B 2,108B EV / Sales 2026 *
2.03x
EV / Sales 2027 * 1.89x
Free-Float
95.47%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 2025-08-17
Director of Finance/CFO 57 2026-09-20
Chief Operating Officer - 2025-11-09
Director TitleAgeSince
Director/Board Member 60 2020-04-21
Chairman 69 2025-12-31
Director/Board Member 62 2021-09-30
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%-2.93% - - 10.34B
-0.03%-1.97%-24.41%+2.88% 175B
-2.69%-5.08%-7.57%+10.67% 114B
+1.25%-2.81%+0.20%+68.22% 57.98B
-1.01%+0.70%-1.42%-30.74% 50.07B
-1.00%+2.74%+13.85%+53.00% 50.13B
-0.05%-2.84%+29.12%-9.24% 32.71B
-0.26%+9.45% - - 30.77B
+0.26%+4.10%+44.02%-0.65% 26.44B
+0.28%+7.74%+26.61%-1.63% 23.96B
Average -0.30%+0.29%+10.05%+11.56% 62.36B
Weighted average by Cap. -0.62%-0.92%-3.29%+12.14%

Financials

2026 *2027 *
Net sales 6.59B 5.81B 5.5B 4.98B 9.36B 633B 9.44B 65.76B 25.37B 323B 24.76B 24.22B 1,037B 6.75B 5.95B 5.63B 5.1B 9.58B 648B 9.66B 67.32B 25.97B 331B 25.34B 24.79B 1,061B
Net income 225M 198M 188M 170M 319M 21.61B 322M 2.25B 866M 11.03B 845M 827M 35.4B 311M 274M 259M 235M 441M 29.83B 445M 3.1B 1.2B 15.23B 1.17B 1.14B 48.86B
Net Debt 3.06B 2.7B 2.55B 2.32B 4.35B 294B 4.38B 30.55B 11.79B 150B 11.5B 11.25B 482B 2.42B 2.14B 2.02B 1.83B 3.44B 233B 3.47B 24.17B 9.32B 119B 9.1B 8.9B 381B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company's segments include Bioscience & Medtech Products and VWR Distribution & Services. Through these segments, it provides materials and consumables, equipment and instrumentation and services and specialty procurement to customers in biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and others.
Employees
13,500
Trader
Investor
Global
Quality
ESG MSCI
-